Article Versions Notes

Cerma K, Piacentini F, Moscetti L, Barbolini M, Canino F, Tornincasa A, Caggia F, Cerri S, Molinaro A, Dominici M, et al. Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines. 2023; 11(1):109. https://doi.org/10.3390/biomedicines11010109

Cerma, Krisida, Federico Piacentini, Luca Moscetti, Monica Barbolini, Fabio Canino, Antonio Tornincasa, Federica Caggia, Sara Cerri, Alessia Molinaro, Massimo Dominici, and et al. 2023. "Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges" Biomedicines 11, no. 1: 109. https://doi.org/10.3390/biomedicines11010109

Cerma, K., Piacentini, F., Moscetti, L., Barbolini, M., Canino, F., Tornincasa, A., Caggia, F., Cerri, S., Molinaro, A., Dominici, M., & Omarini, C. (2023). Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges. Biomedicines, 11(1), 109. https://doi.org/10.3390/biomedicines11010109